An Egyptian study made by Abdelsattar et al. 2022 demonstrated that there was an increase in the expression of genotype frequencies of ACE2 rs2285666 and TMPRSS2 rs1232976 (TT), (CT + TT) and (T) alleles in the severe COVID-19 group compared to control and mild groups. The gene discussed is ACE2; the disease is COVID-19.